Inequitable Conduct "Plague" Cured By Federal Circuit's Therasense Decision

Alleged infringers will have a tougher time proving that a patent applicant deceived the patent office under a new standard set by the U.S. Court of Appeals for the Federal Circuit.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet